Astrana Health, Inc.
Close on Oct 19, 2026
- Market cap
- $1.84B
- P/E (TTM)
- 45.0
- Dividend yield
- –
Earnings
Next report expected Nov 5, 2026, after market close (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 6, 2026 | After market close | $972.50M | $0.40 | $0.80 |
| Q1 FY2026 Ended Mar 31, 2026 | May 7, 2026 | After market close | $965.10M | $0.29 | $0.74 |
| Q4 FY2025 Ended Dec 31, 2025 | Mar 2, 2026 | Before market open | $950.50M | $0.12 | $0.54 |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 6, 2025 | After market close | $956.00M | $0.01 | – |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 7, 2025 | After market close | $654.80M | $0.19 | – |
| Q1 FY2025 Ended Mar 31, 2025 | May 8, 2025 | After market close | $620.40M | $0.14 | – |
| Q4 FY2024 Ended Dec 31, 2024 | Feb 27, 2025 | After market close | $665.20M | $-0.15 | – |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 7, 2024 | After market close | $478.70M | $0.33 | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 7, 2024 | After market close | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 7, 2024 | After market close | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Feb 27, 2024 | After market close | – | – | – |
Company guidance
Outlook given with results on Aug 6, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Adjusted EBITDAnon-GAAP | Three Months Ending September 30, 2026 | $72.50M to $77.50M | New |
| Free cash flownon-GAAP | Year Ending December 31, 2026 | $105.00M to $132.50M | Maintained |
| Total revenue | Three Months Ending September 30, 2026 | $1.00B to $1.03B | New |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Astrana Health filed with the SEC
31 $ Change 12/31/2025 6/30/2026 $ in millions $(28.7) $429.5 $400.8 Cash and cash equivalents 1 $(76.5) $248.0 $171.5 Working capital $47.5 $793.3 $840.8 Total stockholders’ equity 1. Excluding restricted cash and marketable securities. Balance Sheet Highlights
Regulation FD disclosure · EX-99.1 to Form 8-K
Astrana Health, Inc. Reports Second Quarter
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
August 2026 Second Quarter 2026 Earnings Supplement
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Astrana Health ACOs Deliver $120.4
Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
Astrana Health, Inc. Reports First Quarter
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
May 2026 First Quarter 2026 Earnings Supplement
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
of June 30, 2025 and
Other events · EX-99.1 to Form 8-K
UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT
Other events · EX-99.2 to Form 8-K
Astrana Health, Inc. Reports Fourth Quarter
Results of operations · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
March 2026 Fourth Quarter & Full Year 2025 Earnings Supplement
Results of operations · Regulation FD disclosure · Other events · EX-99.2 to Form 8-K
Astrana Health, Inc. Reports Third Quarter 2025
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
include any statements about the Company's business, financial condition, operating results, plans, objectives, expectations and intentions, expansion plans, estimates of our total addressable market, our ability to successfully
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Astrana Health, Inc. Reports Second Quarter
Results of operations · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · EX-99.2 to Form 8-K
Astrana Health Announces Closing of Prospect Health Acquisition
Material agreement · Acquisition or disposition completed · Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
Astrana Health, Inc. Reports First Quarter 2025
Results of operations · EX-99.1 to Form 8-K
(IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)
Results of operations · EX-99.1 to Form 8-K/A
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
Astrana Health, Inc. Reports Fourth Quarter
Results of operations · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
Astrana Health Announces Definitive Agreement
Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Regulation FD disclosure · EX-99.2 to Form 8-K
Astrana Health, Inc. Reports Third Quarter
Results of operations · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
Astrana Health, Inc. Reports Second Quarter
Results of operations · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · EX-99.2 to Form 8-K
Astrana Health Enters Definitive Agreement to
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K